- One Jab. 72% Fewer Sick Babies. SciTechDaily
- Social Factors Affect Access to RSV Prophylaxis in Children Medscape
- Sanofi touts real-world Beyfortus data as Merck & Co.’s RSV rival enters field FirstWord Pharma
- Premature babies in UK to be immunised against winter virus RSV BBC
- Single-injection nirsevimab to protect premature babies against RSV to be rolled out Hospital Healthcare Europe
Source link
